CAL
AGN

Capital Analysts LLC’s Allergan Inc AGN Stock Holding History

Capital Analysts LLC’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-1,338
Closed -$121K – 345
2013
Q3 		$121K Buy
1,338
+145
+12% +$13K 0.04% 163
2013
Q2 		$100K Buy
+1,193
New +$124K 0.03% 166

Other funds holding AGN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Capital Analysts LLC's AGN Position: Q4 2013 in Review

Capital Analysts LLC sold out of Allergan Inc (AGN) in Q4 2013, closing a stake of 1,338 shares — an estimated $121K sold.

Capital Analysts LLC first reported a position in AGN in Q2 2013 and held it in 2 quarters. The position peaked at $121K in Q3 2013. 709 funds tracked by Wall St. Rank hold AGN as of Q4 2013.

  • Capital Analysts LLC reported no remaining Allergan Inc position as of Q4 2013 after selling out during the quarter.
  • Capital Analysts LLC sold 1,338 Allergan Inc shares in Q4 2013, an estimated $121K.
  • Capital Analysts LLC first reported a position in Allergan Inc in Q2 2013 and held it in 2 quarters.
  • Capital Analysts LLC's Allergan Inc position peaked at $121K in Q3 2013.
  • 709 funds tracked by Wall St. Rank held Allergan Inc as of Q4 2013.

Based on Capital Analysts LLC's 13F filing for Q4 2013, filed 12 Nov 2014.